ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 120 filers reported holding ITEOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,079,232 | -17.3% | 98,560 | 0.0% | 0.34% | -5.9% |
| Q2 2023 | $1,304,934 | -2.7% | 98,560 | 0.0% | 0.36% | -11.2% |
| Q1 2023 | $1,341,402 | -30.3% | 98,560 | 0.0% | 0.40% | -25.8% |
| Q4 2022 | $1,924,877 | +3.5% | 98,560 | +1.0% | 0.54% | +8.4% |
| Q3 2022 | $1,859,000 | -14.3% | 97,560 | -7.3% | 0.50% | -15.4% |
| Q2 2022 | $2,169,000 | -24.5% | 105,298 | +17.9% | 0.59% | -21.1% |
| Q1 2022 | $2,874,000 | +14.1% | 89,298 | +65.1% | 0.75% | +18.3% |
| Q4 2021 | $2,518,000 | +12.3% | 54,090 | -34.9% | 0.63% | +6.4% |
| Q3 2021 | $2,243,000 | – | 83,061 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $52,174,000 | 19.87% |
| MPM BioImpact LLC | 1,745,943 | $33,260,000 | 7.88% |
| Boxer Capital, LLC | 2,154,058 | $41,035,000 | 2.31% |
| TANG CAPITAL MANAGEMENT LLC | 937,500 | $17,859,000 | 2.19% |
| RA Capital Management | 4,417,259 | $84,149,000 | 1.80% |
| BVF INC/IL | 1,810,835 | $34,496,000 | 1.42% |
| Zebra Capital Management LLC | 12,271 | $234,000 | 0.89% |
| Integral Health Asset Management, LLC | 195,000 | $3,715,000 | 0.72% |
| Prairiewood Capital, LLC | 32,269 | $615,000 | 0.51% |
| DAFNA Capital Management LLC | 97,560 | $1,859,000 | 0.50% |